$SMR

SMR Stock Slides As Fraud Probe Follows UBS Downgrade

NuScale Power Corporation (NYSE: SMR) shares fell 7.29% on October 12, 2026, amid concerns over project delays, a UBS downgrade, and a fraud probe. UBS cut its price target to $6, citing execution risks and negative free cash flow expectations. SMR reported Q2 2026 revenue of $75,000 and a net loss of $47.54M. Analysts' average price target is $12.37, with a consensus 'Hold' rating.

Original reporting
Published Oct 12, 2026, 7:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 12, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SMR Stock Slides As Fraud Probe Follows UBS Downgrade — source image
Decision brief

The 30-second read

$SMRBearishHigh
01

Why it matters

The combined downgrade and fraud investigation represent a fresh, material catalyst likely to keep selling pressure on SMR for the near term.

02

Market read

The news is a primary disclosure for SMR, creating immediate sell pressure and potential short‑term trading opportunities.

03

What to watch

RBC's Hold stance and an average analyst target of $12.37 suggest some upside potential if the legal risk eases.

Relevance 7/10Novelty 7/10Timing: today

Background

SMR is a penny‑stock focused on small modular nuclear reactors, previously trading in an $8‑$9 range before recent negative catalyst.

Company-level read

Ticker impact

$SMRBearishHigh confidence
Context

UBS downgraded SMR to Sell and cut the price target, and Pomerantz LLP launched a securities‑fraud investigation, driving the stock down 7.3% intraday.

Expected impact

likely further downside as investors price in legal risk and reduced earnings outlook

Evidence & confidence

Both the downgrade and the investigation are fresh, material events for a micro‑cap; no prior coverage existed, and the stock already fell sharply on the news.

Market effects

Highlights heightened risk for other small‑modular reactor and niche clean‑energy firms facing execution uncertainty.

Primarily U.S. micro‑cap investors; limited broader market effect.

Minimal global impact beyond niche energy‑tech investors.

Counterpoint

If the fraud probe stalls or is dismissed, the stock could rebound on its strong cash position and lack of debt.

Key entities

  • NuScale Power Corporation

    Issuer of SMR stock, subject of downgrade and fraud probe.

  • UBS

    Downgraded SMR to Sell and cut price target.

  • Pomerantz LLP

    Launched securities‑fraud investigation into NuScale.

Related articles

$SMRMed

SMR Stock Slides As UBS Downgrade Triggers Legal Scrutiny

NuScale Power Corporation (NYSE: SMR) shares fell 3.13% on October 13, 2026, closing at $6.49. The decline follows a UBS downgrade from Neutral to Sell, with a price target cut from $10 to $6, citing concerns over delayed deployments, weak customer commitments, and cash burn. Additionally, Pomerantz LLP announced an investigation into potential securities fraud, adding to the uncertainty.

$SMRHigh

NuScale Power Is Now Down 49% This Year: Is SMR Stock Dead Money or Due for a Bounce?

NuScale Power (SMR) stock is down 49% year to date, trading at $7.18. The company reported $75,000 in quarterly revenue, a significant drop from the prior year, and plans to sell $750 million in shares. NuScale is a pre-revenue developer of small modular reactors, with no commercial deployment expected until the early 2030s. Investors debate whether the stock is dead money or a bounce candidate.

$SMRHigh

SMR Stock Slides As Legal Probe Follows UBS Downgrade

NuScale Power (SMR) stock fell 5.6% after UBS downgraded it to Sell, cutting its price target to $6 from $10. The firm cited competitive erosion, slow project progress, and lack of customer commitments. Pomerantz LLP also launched an investigation into potential securities fraud. NuScale reported $31.5M in revenue, negative margins, and projected $700M in negative free cash flow from 2026-2028.

$SMRMed

Is NuScale Power Stock a Buy After September Slump?

NuScale Power (SMR) shares fell 14.8% in September 2026, down 55% YTD. UBS downgraded it to sell with a $6 price target, citing cash burn and competition. Q2 revenue dropped 99% to $75k, with a $65M operational loss. NuScale plans to sell up to $750M in new stock. Investors await Q3 earnings for contract updates.

$SMRMed

SMR Stock Slides As UBS Downgrade Triggers Legal Scrutiny

NuScale Power (NYSE: SMR) shares fell 7.17% after UBS downgraded the stock to Sell with a $6 price target, citing concerns over competitive edge, weak customer traction, and cash burn. Pomerantz LLP launched an investigation into potential securities fraud. The company reported $31.5M in revenue, significant losses, and negative cash flow. SMR's valuation is high with an enterprise value near $2.49B and a price-to-sales ratio above 300.